Ecolab Inc. (ECL)
NYSE: ECL
· Real-Time Price · USD
279.98
-1.85 (-0.66%)
At close: Aug 14, 2025, 3:59 PM
278.30
-0.60%
After-hours: Aug 14, 2025, 07:58 PM EDT
Ecolab Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Healthcare And Life Sciences Revenue | 1.43B | 1.59B | 1.57B | 6.3B | 5.96B | 5.57B | 5.46B | 4.88B | 4.62B | 4.86B | 4.87B | 4.91B |
| Global Healthcare And Life Sciences Revenue Growth | -9.58% | +1.02% | -75.10% | +5.79% | +7.00% | +1.97% | +11.97% | +5.66% | -4.95% | -0.18% | -0.78% | n/a |
| Global Institutional and Specialty Revenue | 5.41B | 5B | 4.48B | 3.98B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Global Institutional and Specialty Revenue Growth | +8.30% | +11.59% | +12.61% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Global Pest Elimination Revenue | 1.17B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Global Pest Elimination Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Global Industrial Revenue | 7.86B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Global Industrial Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Asia Pacific Revenue | 1.34B | 1.3B | 1.21B |
| Asia Pacific Revenue Growth | +3.54% | +6.97% | n/a |
| Canada Revenue | 478.7M | 453.1M | 416.2M |
| Canada Revenue Growth | +5.65% | +8.87% | n/a |
| Europe Revenue | 3.19B | 3.22B | 2.96B |
| Europe Revenue Growth | -0.78% | +8.76% | n/a |
| C [N] Revenue | 696.9M | 670.3M | 683.6M |
| C [N] Revenue Growth | +3.97% | -1.95% | n/a |
| Middle East And Africa Revenue | 625.2M | 552.9M | 509.3M |
| Middle East And Africa Revenue Growth | +13.08% | +8.56% | n/a |
| Latin America Revenue | 1.1B | 1.01B | 860.6M |
| Latin America Revenue Growth | +8.45% | +17.85% | n/a |
| United States Revenue | 8.31B | 8.12B | 7.42B |
| United States Revenue Growth | +2.34% | +9.32% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.07B | 1.05B | 1.05B | 1.03B | 1.07B | 1.08B | 1.04B | 1.01B | 1B | 959.7M | 876.3M | 979.2M | 1.01B | 942.8M | 955.9M | 896.9M | 837.6M | 847M | 809.6M | 670.9M | 783.1M | 924.4M | 907.5M | 883.2M | 934.5M | 1B | 1.01B | 984.2M | 1.13B | 952.3M | 886.2M | 802M | 884.1M | 1.1B | 1.09B | 1.06B | 1.09B | 1.09B | 1.06B | 1.07B | 1.08B | 1.14B |
| Selling, General, and Administrative Revenue Growth | +1.62% | -0.12% | +2.31% | -4.05% | -0.67% | +3.25% | +3.62% | +0.46% | +4.58% | +9.52% | -10.51% | -3.29% | +7.39% | -1.37% | +6.58% | +7.08% | -1.11% | +4.62% | +20.67% | -14.33% | -15.29% | +1.86% | +2.75% | -5.49% | -6.57% | -1.33% | +3.00% | -12.72% | +18.41% | +7.46% | +10.50% | -9.29% | -19.50% | +0.96% | +2.62% | -3.05% | +0.47% | +2.78% | -1.11% | -0.79% | -5.07% | n/a |
| Research and Development Revenue | n/a | n/a | 207M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 191M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |